Promoting and facilitating strategies to improve cardiovascular health worldwide
-
Conferences & Events
Organising high level conferences featuring presentations, seminars and discussions and attended by world-renowned consultants.
-
Webinars & e‑Learning
Specific training and best-practice modules, including ISCP on-demand webinars and ISCP-endorsed webinars
-
Expert Reviews & Analysis
Expert Reviews, Opinions and Brief Reports. Independent summary information to keep you up to date with the latest research.
-
Drug Interaction Database
A reference tool for cardiovascular physicians and surgeons, pharmacists, pharmacologists, scientists and medical practitioners.
2024 ISCP GENERAL ASSEMBLY
Wednesday 15th May @12.00 BST
Dear esteemed ISCP members,
We are pleased to inform that a date has been set for our 2024 General Assembly. It will take place fully online over zoom on Wednesday 15th May @12.00 BST. Please block your calendars and attend this important yearly meeting. We hope to see you all at the GA this year.
We will be in touch again over email closer to the date to share the agenda and any other relevant documents for your consideration. Only Full Members, Associate Members, and Emeritus Members in good standing are eligible to partipate. If you are entitled to take part but have not received your invitation please get in touch with Lourdes Marenco
A-Z of CV Pharmacotherapy:
ISCP Webinar Series
Our first five webinars produced in collaboration with our partners Radcliffe Cardiology are now available to view in the Webinars On Demand section:
1- Ferric Carboxymaltose: Ironing Out the Issues Around Heart Failure-Related Readmissions,
2- Inclisiran: A Jab Goes a Long Way,
3- Edoxaban: ENGAGEing in Individualisation of DOACs,
4- Valsartan Sacubitril: Has our PARADIGM shifted?,
5- Clopidogrel or Ticagrelor: Why, When, for Whom?, and
Details of future webinars will become available in Upcoming webinars very soon, including the next series of our own A to Z of CV Pharmacotherapy programme
Have you watched one or more of the above sessions? We value your opinion. Take 3 minutes to give us feedback on the series.
Upcoming Events
30
Aug
ESC 2024 LONDON
Conferences 30 Aug 2024
31
Oct
ISCP 2024 BRAZIL
Annual Meeting 31 Oct 2024
Highlights
The latest reviews, resources and expert analysis from our website.
newsfeed
Metformin use linked to lower risk for rare blood cancer
Posted on May 17, 2024
Individuals prescribed the antidiabetes treatment metformin less likely developed a myeloproliferative neoplasm —potentially also reducing a person’s chances for developing certain cancers... more
FDA clears AI algorithm for detection of worsening HF
Posted on May 17, 2024
Implicity announced it received 510(k) clearance from the FDA for its new AI algorithm to assess risk for future HF events from... more
Phenotype-negative athletes with genetic heart disease OK to play sports
Posted on May 17, 2024
No athlete with a positive test for genetic heart disease but a negligible clinical phenotype had a genetic heart disease-associated death or... more
Real-world 30-day data show noninferiority of new TAVR valve vs. other contemporary valves
Posted on May 17, 2024
A new prosthetic aortic valve with a wider range of intermediate sizing was noninferior at 30 days vs. other contemporary transcatheter aortic... more
ISCP book series
Current Cardiovascular Therapy
Kaski, Juan Carlos.
Series Editor: Juan Carlos Kaski Cardiovascular pharmacotherapy is a fast-moving and complex discipline within cardiology in general. New studies, trials and indications are appearing on a regular basis. This series created with the support of the International Society of Cardiovascular Pharmacotherapy (ISCP) is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis. The information within is designed to allow readers to learn quickly and with certainty the mode of action,...
-
Antiplatelet and Anticoagulation Therapy
A. Ferro, D.A. Garcia (Eds.)
-
Pharmacological Treatment of Acute Coronary Syndromes
Avanzas, Pablo; Clemmensen, Peter(Eds.)
-
Atrial Fibrillation Therapy
Gheorghe-Andrei Dan, Antoni Bayes de Luna, John Camm(Eds.)
board of directors
Providing a leadership and advocacy role amongst members of their national societies.
-
Alberto Lorenzatti
President
Dr. Alberto J. Lorenzatti is currently the Co-Director of the DAMIC Medical Institute / Rusculleda Foundation for Research, Teaching and Patient Care (Head of the Clinical Research network with more than 30 research sites in Argentina) and he was the Chief of Cardiology at the Cordoba Hospital, Cordoba, Argentina... more
-
Sang Hong Baek
Board Member
Sang Hong Baek is a Board Member of ISCP and also Governor for the Republic of Korea. ISCP Governors act as representatives for different countries worldwide to encourage local participation and contribute to the ISCP's educational programmes. Past president of the ISCP Professor Sang Hong Baek is Director of Heart... more
-
Thomas Kahan
Past President
Affiliations/Memberships Professor of Medicine Department of Clinical Sciences, Danderyd Hospital Division of Cardiovascular Medicine (more…) more
-
Pablo Avanzas
Secretary
Professor Pablo Avanzas is Director of Invasive Cardiology at Hospital Universitario Central de Asturias and Full Professor of Cardiology at University of Oviedo in Asturias, Spain. Affiliations/Memberships • Full Professor of Cardiology, University of Oviedo, Oviedo, Spain. • Director of Invasive Cardiology at Hospital Universitario Central de Asturias, Oviedo,... more
